Trump, Medicare
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The Inflation Reduction Act (IRA) of 2022 brought substantial modifications to the Medicare program, which are still reflected in 2025. One of these changes was a new limit for ded ...
The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs. The cap will reduce out-of-pocket spending for potentially millions of older ...
As of Jan. 1, 2025, people with prescription drug coverage through Medicare Part D or a Medicare Advantage Plan have a $2,000 spending cap on out-of-pocket costs for prescriptions covered by ...
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
True out-of-pocket costs are payments that count toward your Medicare prescription drug plan’s out-of-pocket maximum. Once you meet this maximum, you won’t pay for prescriptions for the rest ...
If you’re steamed to discover your favorite doctor is no longer in your Medicare Advantage plan’s network, now is the time to make a change. Medicare Advantage enrollees can switch plans or transfer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback